FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36910511000001100: Glydex 160mg tablets (Medreich Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Apr 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
113212001000001114 Glydex 160mg tablets (Medreich Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
113212101000001110 Glydex 160mg tablets (Medreich Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Glydex 160mg tablets (Medreich Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) Is a Gliclazide 160mg tablets true Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) Has active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) Has excipient Lactose false Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) Is a Glydex true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Glydex 160mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has AMP True Glydex 160mg tablets (Medreich Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start